ChristianaCare

All visitors are required to wear masks.

For COVID-19 safety, all visitors to ChristianaCare facilities and services are required to wear masks. This includes visitors who are vaccinated. Please read our visitor guidelines before arrival.

Major I-95 roadwork. Plan ahead for your good health.

Expect delays and allow extra time to reach ChristianaCare locations.

Learn more at christianacare.org/I95

Clinical Trials

OB/GYN Clinical Trials

These are among the clinical trials and studies currently open:

Title Randomized Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation with a Short Cervix (PROSPECT).
Purpose
The purpose of this research study is to find out whether pessary or vaginal progesterone lowers the risk of babies being born preterm to women with a short cervix. A pessary is a round, soft silicone device that goes around the cervix. Progesterone is a hormone naturally produced by the placenta.
Qualifications
  • Pregnant with twins.
  • Gestational age between 16 weeks and 24 weeks.
  • Cervical length less than 30 mm
Benefits
If you decide to participate in this research study, you and your babies may not directly benefit. If the study shows that treatment is successful, you and your babies may benefit if you are assigned to receive the progesterone medication or a pessary. Your participation can potentially benefit mothers and their babies in the future.
Contact Please contact OB/GYN Research at 302-733-3065 or page us at 302-573-7413 or email us at OBGYNResearch@ChristianaCare.org.
Title A Pragmatic Multicenter Randomized Trial Hypertensive Therapy for Mild Chronic Hypertension during Pregnancy: Chronic Hypertension and Pregnancy (CHAP) Project.
Purpose
This study will evaluate the safety and benefits of treating mild chronic hypertension (CHTN) or high blood pressure, during pregnancy. We are conducting this study to find out whether treating pregnant women with mild CHTN with blood pressure medicines to lower their blood pressure below 140/90 is safe and beneficial for the mother and baby.
Qualifications
  • Less than 18 weeks pregnant.
  • Pregnant with one baby.
  • Have high blood pressures(s).
Benefits
If you decide to participate in this research study, you and your baby may not directly benefit. Your participation may help doctors determine if it is medically beneficial to treat mild CHTN during pregnancy for both mom and baby in the future.
Contact Please contact OB/GYN Research at 302-733-3065 or page us at 302-573-7413 or email us at OBGYNResearch@ChristianaCare.org.
Title Pregnancy as a Window to Future Cardiovascular Health: Adverse Pregnancy Outcomes as Predictors of Increased Risk Factors for Cardiovascular Disease (U10) (the nuMoM2b Heart Health Study)
Purpose
The nuMoM2b cohort provides an opportunity to evaluate the association between adverse pregnancy outcomes and maternal health later in life. The study is looking at links between pregnancy experiences, heart health, and related conditions. This includes looking at factors related to heart and blood vessel diseases, stroke, lung diseases, sleep problems, diabetes, and kidney disease. It also includes experiences during the nuMoM2b pregnancy and later pregnancies. This is a follow-up study to the nuMoM2b Study. We will be contacting nuMoM2b study participants to see if they are interested in participating.
Qualifications
  • You participated in the nuMoM2b study and you agreed to be contacted in the future.
Benefits
  • This study capitalizes on the rich and unique data already collected in nuMoM2b Study. The information collected will contribute significantly to our understanding of how pregnancy outcomes are linked to future
    health.
  • By participating in this study it may help identify risk factors for heart disease in women, develop early detection methods for heart disease risk in women and delay or prevent heart disease in women.
Contact Please contact OB/GYN Research at 302-733-3065 or page us at 302-573-7413 or email us at OBGYNResearch@ChristianaCare.org.
Title A Randomized Trial of Induction Versus Expectant Management (ARRIVE)
Purpose The study will determine whether coming to the hospital and having your labor started “(induced)” with medicine at 39 weeks of pregnancy can improve the baby’s health at birth when compared with waiting for labor to start on its own.
Qualifications
  • Pregnant women ages 18 years of age or older having your first baby.
    No previous pregnancies beyond 20 weeks gestation.
    Singleton gestation.
    Gestational age at randomization between 38 weeks 0 days and 38 weeks 6 days.
Benefits
  • Participation may help doctors determine the best time to plan for deliveries in the future.
    Participants will receive a modest compensation to reimburse them for time required to participate.
Contact OB/GYN Research 302-733-2919 or pager 302-573-7413.
Title An Observational Study of Hepatitis C Virus in Pregnancy (HCV)
Purpose This observational study will allow a better understanding of HCV in pregnancy and will review the clinical and laboratory predictors of the risk of transmission to the fetus and newborn.
Qualifications
  • Singleton pregnancy.
    Positive HCV antibody screen.
    Gestational age at screening no later than 23 weeks and 6 days and gestational age at enrollment no later than 27 weeks and 6 days.
Benefits
  • Participation may help doctors in the future find better treatments for mothers and babies.
    Participants will receive a modest compensation to reimburse them for time required to participate.
Contact OB/GYN Research 302-733-2919 or pager 302-573-7413.
Title A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Purpose This study aims to screen pregnant women in the first half of pregnancy for recent primary CMV infection and evaluate in a proper randomized clinical trial whether maternal administration of CMV hyperimmune globulin will prevent congenital CMV infection.
Qualifications
  • Diagnosis of primary maternal CMV infection.

  • Singleton pregnancy.

  • Gestational age at enrollment no later than 23 weeks 6 days.

Benefits Participation may help doctors in the future find better treatments for mothers and babies.Participants will receive a modest compensation to reimburse them for time required to participate.
Contact OB/GYN Research 302-733-2919 or pager 302-573-7413.

OB/GYN Research Department
Christiana Hospital, Room 2905
4755 Ogletown-Stanton Road, Newark, DE 19718 directions
302-733-3576

obgynresearch@christianacare.org